Lipid nanoparticles deliver one-two punch to shrink resistant oral tumors in preclinical models
Oral squamous cell carcinoma (OSCC) is the most common form of head and neck cancer, and the number of new cases is predicted to rise by 30% in the next decade. Despite decades of cancer research, treating OSCC remains a ...